Related Experiment Video
Updated: Dec 16, 2025

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
Electronic adherence monitoring identifies severe preschool wheezers who are steroid responsive
Yvonne Bingham1,2, Nina Sanghani2, James Cook1,3
1Department of National Heart and Lung Institute, Imperial College London, UK.
Insights
Adherence to inhaled corticosteroids (ICS) in preschool children with wheeze is often poor. Symptom control improved with ICS, but only in atopic children with good adherence.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Preschool troublesome wheeze is common, but adherence to inhaled corticosteroids (ICS) is poorly understood.
- Children with aeroallergen sensitization or multiple trigger wheeze (MTW) may have better ICS response.
Purpose of the Study:
- To investigate the relationship between ICS adherence and symptom control in preschool children with troublesome wheeze.
- To determine if this relationship differs in atopic children or those with MTW.
Main Methods:
- Recruited 48 preschool children (1-5 years) with recurrent wheeze on ICS.
- Assessed adherence using electronic monitoring (Smartinhaler).
- Evaluated symptom control (TRACK), quality of life (PACQLQ), and airway inflammation (exhaled nitric oxide).
Main Results:
- 50% of children had suboptimal ICS adherence (<80%), with a median adherence of 64%.
- Overall symptom control and quality of life improved, independent of adherence.
- Only atopic wheezers with adherence ≥60% showed significant improvement in symptom control (TRACK).
Conclusions:
- Suboptimal ICS adherence is prevalent in preschool children with troublesome wheeze.
- Positive association between ICS adherence and symptom control was observed only in atopic wheezers.
- Assessing adherence is crucial before escalating therapy to identify ICS-responsive phenotypes.
Abstract:
Little is known about adherence to inhaled corticosteroids (ICS) in preschool children with troublesome wheeze. Children with aeroallergen senitization, or those reporting multiple trigger wheeze (MTW), are more likely to respond to ICS. We hypothesized that adherence to ICS and symptom control are only positively related in atopic children, or those reporting MTW. Patients aged 1 to 5 years with recurrent wheeze prescribed ICS were recruited from a tertiary respiratory clinic. Clinical phenotype and aeroallergen senitization were determined, and adherence assessed using an electronic monitoring device (Smartinhaler). Symptom control (test for respiratory and asthma control in kids [TRACK]), quality of life (PACQLQ), airway inflammation (offline exhaled nitric oxide) were assessed at baseline and follow-up. Forty-eight children (mean age 3.7 years; SD, 1.2) were monitored for a median of 112 (interquartile range [IQR], 91-126) days. At baseline n = 29 reported episodic viral wheeze and n = 19 reported MTW. Twenty-four out of 48 (50%) wheezers had suboptimal ICS adherence (<80%). Median adherence was 64% (IQR, 38-84). There was a significant increase in TRACK and PACQLQ in the group as a whole, unrelated to adherence. In subgroup analysis only atopic wheezers with moderate or good adherence ≥ 60% had a significant increase in TRACK. There was no relationship between clinical phenotype, and adherence or TRACK. In this pilot study, overall adherence to ICS was suboptimal and was positively related to symptom control in atopic wheezers only. Assessments of adherence are important in preschool troublesome wheezers before therapy escalation to help identify those with an ICS responsive phenotype.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Nursing Management
First, in...
Asthma-III: Symptoms and Complications
Classification of Asthma
COPD: Management Using Bronchodilators and Corticosteroids

